samedan logo
 
 
spacer
home > pmps > summer 2003 > changing times for process automation in the pharmaceutical sector
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Changing Times for Process Automation in the Pharmaceutical Sector

For once the professional fortune tellers are in agreement - pharmaceuticals look set to provide a rare opportunity for significant growth in an otherwise difficult market for process automation suppliers over the coming years. This article will attempt to explain the reasons for this and looks at some of the latest technology available for use throughout the pharmaceutical industry.

According to a recent report from US-based pundits at the ARC Advisory Group, the global pharmaceutical and food and drink industries will provide the biggest growth opportunities for automation suppliers until at least 2006. The growth in the total automation market limped along at less than one per cent in 2000-2001 and ARC expects this to reach an average of just 3.4 per cent a year through to 2006. Larry O'Brien, ARC's Director of Research for the process industries, says: "In this environment of limited growth, the food and beverage and pharmaceutical industries will offer the strongest potential opportunity in the long term."


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Roger Trew, European Development Advisor for the International Society for Pharmaceutical Engineering (ISPE)

Roger Trew is European Development Advisor for the International Society for Pharmaceutical Engineering (ISPE). He is writing on behalf of TOTAL Processing and Packaging, a new event which combines Interphex, Eurochem, Pakex and the PPMA Machinery Only show. The show will focus on all elements relevant to the processing and packaging value chain and will take place at Birmingham NEC, UK, from 29th March to 1st April 2004.

spacer
Roger Trew
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

Small Scale Biomanufacturing – clinical trials, cell & gene therapies

18 September 2008, Clifton Pavilion, Bristol Zoo Gardens, Bristol

This one day conference, sponsored by bioProcessUK and organised by BioApproaches South West, will cover key, important topics relating to small scale GMP biomanufacturing.
More info >>

 
News and Press Releases

Azopharma Announces Plans to Implement XcelodoseTM Technology in the Production of Early Stage Clinical Trial Materials

HOLLYWOOD, Fla. – Azopharma Product Development Group, Inc. (“Azopharma”) announced today plans to implement Xcelodose technology at its formulations development facility, ApiCross Drug Delivery Technologies. Xcelodose technology is a powder micro-dosing system developed by Meridica. This technology offers a unique powder dispensing system for small-scale capsule filling and ultimately assists in conserving valuable research material as well as reducing various Preformulation activities.
More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement